OB/Gyn
News, opinions and meeting coverage in obstetrics and gynecology.
Medicare to Keep Paying for Avastin
WASHINGTON -- Medicare will continue to pay for bevacizumab (Avastin) when it's used to treat metastatic breast cancer, even if the FDA decides to remove that indication from the drug, a spokesman for the Centers for Medicare and Medicaid Services (CMS) said.
Jun 30, 2011
Some Birth Control Pills Pose Gallstone Risk
Some of the newest and most popular oral contraceptives -- including the drospirenone/ethinyl estradiol combo marketed as Yaz -- have been linked to a small, but significant risk of gallbladder disease, according to a large retrospective cohort study.
Apr 20, 2011